NCT01675791View on ClinicalTrials.gov

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

PHASE2CompletedINTERVENTIONAL
Enrollment

637

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions
Birch Pollen Allergy
Interventions
BIOLOGICAL

ALK tree AIT 0.5 DU

BIOLOGICAL

ALK tree AIT 1 DU

BIOLOGICAL

ALK tree AIT 2 DU

BIOLOGICAL

ALK tree AIT 4 DU

BIOLOGICAL

ALK tree AIT 7 DU

BIOLOGICAL

ALK tree AIT 12 DU

BIOLOGICAL

ALK tree AIT Placebo

Trial Locations (2)

00029

Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki

1066EC

Slotervaart Ziekenhuis, Amsterdam

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01675791 - A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet | Biotech Hunter | Biotech Hunter